Clinical Trials Directory

Trials / Terminated

TerminatedNCT01486550

Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy

Effect of Hydroxyethyl Starch on Renal Handling of Salt and Water, Blood Pressure-regulating Hormones, Proteins and Circulatory System of Patients Undergoing Kidney Removal by Keyhole Surgery

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Regional Hospital Holstebro · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this project is to investigate if hydroxyethyl starch (HES) is potential nephrotoxic and examine the effects on the circulation and kidneys during administration of HES during surgery.

Detailed description

Hydroxyethyl starch (HES) is widely used in hospitals to maintain circulation in critically ill patients. In recent years studies have raised suspicion that HES is nephrotoxic. So far acute kidney injury has been diagnosed based on creatinine measurements, but new technology allows for earlier diagnosis using measurements of biomarkers in urine. The purpose of this project is to investigate HES's potential toxicity and effects on the circulation and kidneys using measurements of biomarkers specific for toxicity and for the sodium/water balance in the urine and by measurements of vasoactive hormones in the blood after administration of HES 130/0.4

Conditions

Interventions

TypeNameDescription
DRUGVoluven (Hydroxyethyl starch 130/0,4)7,5 ml/kg in the first hour and then 5 ml/kg minimum
DRUGSodium Chloride 9mg/ml7,5 ml/kg in the first hour and then 5 ml/kg

Timeline

Start date
2011-12-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2011-12-06
Last updated
2014-10-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01486550. Inclusion in this directory is not an endorsement.